-
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
-
Citi Reiterates Buy Rating on Arcus Biosciences (RCUS)
-
Arcus Biosciences (RCUS) PT Raised to $38 at Citi
-
Arcus Biosciences to Participate in Multiple Upcoming Investor Conferences
-
Arcus Biosciences to Participate at Upcoming Virtual Investor Events
-
Citi Puts Out New Positive Catalyst Watch on Four Names (earlier)
-
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
-
Arcus Biosciences to Participate at Upcoming Investor Conferences
-
Arcus Biosciences (RCUS) Announces Return of Jennifer Jarrett as COO
-
Jennifer Jarrett Returns to Arcus Biosciences as Chief Operating Officer
-
Arcus Biosciences to Participate in Upcoming September 2020 Investor Conferences
-
Arcus Biosciences (RCUS) Prices 11M Share Common Offering at $27.50/Sh
-
Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock
-
Arcus Biosciences (RCUS) Commences Underwritten Public Offering of Common Stock
-
Arcus Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock
-
Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
-
Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
-
Pre-Open Stock Movers 04/16: (RCUS) (LOVE) (BBBY) Higher; (DO) (RAD) (ATHX) Lower (more...)
-
After-Hours Stock Movers 04/15: (RCUS) (AM) (BBBY) Higher; (ATHX) (CALA) (LAKE) Lower (more...)
-
Arcus Biosciences to Present at Upcoming Investor Conferences
-
Arcus Biosciences (RCUS) PT Lowered to $15 at Citi
-
Citi Assumes Arcus Biosciences (RCUS) at Buy
-
Arcus Biosciences Announces Participation at Two Investor Conferences in September
-
Arcus Biosciences (RCUS) Announces Promotion of Jennifer Jarrett to COO
-
Arcus Biosciences Announces the Promotion of Jennifer Jarrett to Chief Operating Officer
-
Citi Starts Arcus Biosciences (RCUS) at Buy
-
Arcus Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Arcus Biosciences (RCUS) IPO Opens 33% Higher
-
Arcus Biosciences (RCUS) Prices 8M Share IPO at $15/Sh
-
Arcus Biosciences Announces Pricing of Initial Public Offering

